UNSPSC 51102809: Acetic/benzalkonium/parachlorometoxylenol/pramoxine/propylene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT109. This VA Drug Class (OT109) classifies this compound as belonging to the group ANTI-INFECTIVES, TOPICAL OTIC OTHER.

UNSPSC 51102809 Acetic/benzalkonium/parachlorometoxylenol/pramoxine/propylene is a Commodity code that shows minimal recent alignment with state and local procurement activity. The code's nominal scope describes active pharmaceutical ingredients and antimicrobial compounds, yet the recent solicitations tagged under it—naloxone procurement, direct-to-manufacturer prescription programs, fire department medical supplies, and generic pharmaceutical distribution—do not center on the specific chemical formulations the code names. The mismatch suggests that issuing bodies are using this code as a catch-all for pharmaceutical and medical-supply contracting rather than as a precise descriptor of chemical inputs. State and local buyers treating this code broadly span county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple jurisdictions including Oregon).

Recent opportunities under this code originate in Florida, Texas, and Minnesota, with cooperative purchasing extending the geographic reach to Oregon and beyond. Representative solicitations include Seminole County's IFB 60459723LAS (due Jul 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually; the City of Tampa's IFB 26P00145 (due Mar 13, 2026) for 169 line items of medical and first aid supplies totaling $700,000, with a 5 percent bid discount for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (due Mar 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers AmerisourceBergen, Cardinal Health, and Morris & Dickson. The Texas HHS RFI HHS0017013 (posted Apr 3, 2026) represents exploratory procurement activity for direct-to-manufacturer prescription programs but carries no award value or timeline. Vendors pursuing this code should clarify scope with issuing bodies before bidding, as the code's technical definition does not reliably predict the actual products and services being solicited.